نتائج البحث

Pair combinations of human monoclonal antibodies fully protected mice against bunyavirus SFTSV lethal challenge.

• Authors : Li B; State Key Laboratory of Virology, School of Public Health, Wuhan University, Wuhan, China.; Qin XR

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/immunology ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/pharmacology ; Phlebovirus*/Phlebovirus*/Phlebovirus*/immunology SFTS phlebovirus

• Source: PLoS pathogens [PLoS Pathog] 2025 Jan 31; Vol. 21 (1), pp. e1012889. Date of Electronic Publication: 2025 Jan 31 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.

• Authors : Phan, Tin¹ (AUTHOR); Zitzmann, Carolin¹ (AUTHOR); Chew, Kara W.² (AUTHOR)

• Source: PLoS Pathogens. 4/18/2024, Vol. 20 Issue 4, p1-21. 21p.

تفاصيل العنوان

Enhancing the therapeutic potential of P29 protein-targeted monoclonal antibodies in the management of alveolar echinococcosis through CDC-mediated mechanisms.

• Authors : Zhang C; School of Basic Medicine, Ningxia Medical University at Yinchuan, Yinchuan, Ningxia, China.; Ningxia Key Laboratory of Prevention and Control of Common Infectious Disease at Yinchuan, Yinchuan, China.

Subjects: Echinococcosis*/Echinococcosis*/Echinococcosis*/drug therapy ; Echinococcosis*/Echinococcosis*/Echinococcosis*/immunology ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/pharmacologyAlveolar echinococcosis

• Source: PLoS pathogens [PLoS Pathog] 2024 Aug 23; Vol. 20 (8), pp. e1012479. Date of Electronic Publication: 2024 Aug 23 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Conserved antigen structures and antibody-driven variations on foot-and-mouth disease virus serotype A revealed by bovine neutralizing monoclonal antibodies.

• Authors : Li, Kun¹ (AUTHOR); He, Yong^2,3 (AUTHOR); Wang, Li¹ (AUTHOR)

• Source: PLoS Pathogens. 11/20/2023, Vol. 19 Issue 11, p1-25. 25p.

تفاصيل العنوان

A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern.

• Authors : Parray, Hilal Ahmad¹ (AUTHOR); Narayanan, Naveen² (AUTHOR); Garg, Sonal¹ (AUTHOR)

• Source: PLoS Pathogens. 12/12/2022, Vol. 18 Issue 12, p1-20. 20p.

تفاصيل العنوان

Cryo-EM reveals the conformational epitope of human monoclonal antibody PAM1.4 broadly reacting with polymorphic malarial protein VAR2CSA.

• Authors : Raghavan, Sai Sundar Rajan¹ (AUTHOR); Dagil, Robert¹ (AUTHOR); Lopez-Perez, Mary¹ (AUTHOR)

• Source: PLoS Pathogens. 11/16/2022, Vol. 18 Issue 11, p1-20. 20p.

تفاصيل العنوان

Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody.

• Authors : Piepenbrink, Michael S.¹ (AUTHOR); Park, Jun-Gyu² (AUTHOR); Deshpande, Ashlesha³ (AUTHOR)

• Source: PLoS Pathogens. 7/21/2022, Vol. 18 Issue 7, p1-25. 25p.

تفاصيل العنوان

Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans.

• Authors : Holzer, Barbara¹ (AUTHOR); Rijal, Pramila^2,3 (AUTHOR); McNee, Adam^1,4 (AUTHOR)

• Source: PLoS Pathogens. 3/4/2021, Vol. 17 Issue 3, p1-25. 25p.

تفاصيل العنوان

Neutralizing monoclonal antibodies against the Gc fusion loop region of Crimean–Congo hemorrhagic fever virus.

• Authors : Li, Liushuai^1,2 (AUTHOR); Chong, Tingting^1,2 (AUTHOR); Peng, Lu^1,2 (AUTHOR)

• Source: PLoS Pathogens. 2/1/2024, Vol. 20 Issue 2, p1-22. 22p.

تفاصيل العنوان

Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques.

• Authors : Edwards CT; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.; Karunakaran KA

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/therapy

• Source: PLoS pathogens [PLoS Pathog] 2025 Jan 23; Vol. 21 (1), pp. e1012456. Date of Electronic Publication: 2025 Jan 23 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان